Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...

Alcon Inc. ALC recently announced the availability of Clareon Vivity — the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform ...

Please provide your email address to receive an email when new articles are posted on . For almost 20 years now, we have been using presbyopia-correcting lens implants. But an important caveat that ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...

TORONTO , Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ® , a first-of-its-kind, surgical lens ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced the commercial launch of the first and only presbyopia-correcting intraocular lens (PC-IOL) with ...

Cataracts are the most common cause of vision loss globally and the primary cause of preventable blindness in India. Bengaluru based Alcon Laboratories India Pvt Ltd has launched presbyopia-correcting ...

Please provide your email address to receive an email when new articles are posted on . Last month, we started a conversation about extended focus IOLs and what makes a patient a good or bad candidate ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...